Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
TANNIR, NIZAR M
One or more keywords matched the following items that are connected to TANNIR, NIZAR M
Item TypeName
Academic Article Ischemic optic neuropathy associated with low-dose interferon alfa: report of two cases.
Academic Article Perfusion CT in patients with metastatic renal cell carcinoma treated with interferon.
Concept Interferon-alpha
Academic Article Improved tolerability and quality of life with maintained efficacy using twice-daily low-dose interferon-alpha-2b: results of a randomized phase II trial of low-dose versus intermediate-dose interferon-alpha-2b in patients with metastatic renal cell carcinoma.
Academic Article Patterns of disease progression in metastatic renal cell carcinoma patients treated with antivascular agents and interferon: impact of therapy on recurrence patterns and outcome measures.
Academic Article Cytokines and angiogenic factors in patients with metastatic renal cell carcinoma treated with interferon-alpha: association of pretreatment serum levels with survival.
Academic Article Curability of poor-risk metastatic sarcomatoid renal cell carcinoma with the combination of gemcitabine, 5-fluorouracil, and interferon-alfa: a case report of a 55-year-old man with a 10-year complete remission.
Academic Article Upfront, randomized, phase 2 trial of sorafenib versus sorafenib and low-dose interferon alfa in patients with advanced renal cell carcinoma: clinical and biomarker analysis.
Academic Article A cytokine and angiogenic factor (CAF) analysis in plasma for selection of sorafenib therapy in patients with metastatic renal cell carcinoma.
Academic Article Treatment-related optimism protects quality of life in a phase II clinical trial for metastatic renal cell carcinoma.
Academic Article Acute pancreatitis associated with interferon alpha therapy for chronic myelogenous leukemia.
Academic Article Prospective assessment of systemic therapy followed by surgical removal of metastases in selected patients with renal cell carcinoma.
Search Criteria
  • Interferon alpha